Shakil Ian 4
4 · Augmedix, Inc. · Filed Aug 19, 2024
Insider Transaction Report
Form 4
Augmedix, Inc.AUGX
Shakil Ian
DirectorChief Strategy Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-08-15−3,750→ 116,250 total→ Common Stock (3,750 underlying) - Exercise/Conversion
Common Stock
2024-08-15+3,750→ 11,451 total - Tax Payment
Common Stock
2024-08-15$2.27/sh−1,412$3,205→ 10,039 total - Award
Restricted Stock Units
2024-05-07+60,000→ 120,000 total→ Common Stock (60,000 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Augmedix, Inc. (the "Issuer") common stock.
- [F2]The RSU is granted under the Issuer's 2020 Equity Incentive Plan. One-sixteenth (1/16th) of the RSU will vest quarterly in equal increments over four (4) years commencing on 05/15/2024, with the first one-sixteenth (1/16th) vesting on 08/15/2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F3]Represents an original award of 60,000 RSUs to acquire shares of the Company's common stock. The RSU is granted under the Issuer's 2020 Equity Incentive Plan. One-sixteenth (1/16th) of the RSU will vest quarterly in equal increments over four (4) years commencing on 05/15/2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The RSU award vested with respect to one-sixteenth (1/16th) of the units on 08/15/2024.